Авторы

  • Shagazatova B.X., Rakhimberdiyeva Z.A.

Ключевые слова:

Chronic kidney disease; cystatin C.

Библиографические ссылки

1. Åkesson, A., Öberg, C. M., Malmgren, L., Nilsson, C., Itoh, Y., Blirup-Jensen, S., Lindström, V., Abrahamson, M., Leion, F., Ólafsson, Í., Bjursten, H., Grubb, D., Herou, E., Dardashti, A., Sigurjonsson, J., Xhakollari, L., Laučytė-Cibulskienė, A., Pottel, H., Strevens, H., … Grubb, A. (2025). Identification of cystatin C as a new marker of glomerular filtration rate, and of shrunken pore syndrome – a new kidney disorder defining selective glomerular hypofiltration syndromes – calls for expansion of the international KDIGO guidelines. Scandinavian Journal of Clinical and Laboratory Investigation, 85(6), 409. https://doi.org/10.1080/00365513.2025.2546320

2. Al-Hazmi, S. F., Gad, H., Alamoudi, A. A., Eldakhakhny, B., Binmahfooz, S., & Alhozali, A. (2020). Evaluation of early biomarkers of renal dysfunction in diabetic patients. Saudi Medical Journal, 41(7), 690. https://doi.org/10.15537/smj.2020.7.25168

3. AL-Nasrawii, M. S., Jasim, B. S., & Hassan, S. H. (2020). A COMPARATIVE ASSESSMENT OF SERUM CREATININE AND CYSTATIN C AS A SIGNIFICANCE OF NEPHROPATHY IN DIABETIC PATIENTS. Malaysian Journal of Public Health Medicine, 20(3), 189. https://doi.org/10.37268/mjphm/vol.20/no.3/art.527

4. Alobaidi, S. (2025). Emerging Biomarkers and Advanced Diagnostics in Chronic Kidney Disease: Early Detection Through Multi-Omics and AI. Diagnostics, 15(10), 1225. https://doi.org/10.3390/diagnostics15101225

5. Al-Saedy, A. A. K., Turki, K. M., & Nadaa, S. Z. (2017a). Effect of serum cystatin C in early diabetic nephropathy in type 2 Iraqi diabetic patients. Journal of Contemporary Medical Sciences, 3(10), 208. https://doi.org/10.22317/jcms.v3i10.152

6. Al-Saedy, A. A. K., Turki, K. M., & Nadaa, S. Z. (2017b). Effect of serum cystatin C in early diabetic nephropathy in type 2 Iraqi diabetic patients. Journal of Contemporary Medical Sciences, 3(10), 208. https://doi.org/10.22317/jcms.06201702

7. Buturović, B. A. –, & Čavaljuga, S. (2005). Cystatin C as a marker for detection of early renal failure in diabetes type 2 patients. Bosnian Journal of Basic Medical Sciences, 5(4), 68. https://doi.org/10.17305/bjbms.2005.3237

8. Duan, A., Huang, Z., Zhao, Z., Zhao, Q., Jin, Q., Yan, L., Zhang, Y., Li, X., Zhang, S., Hu, M., Gao, L., An, C., Luo, Q., & Liu, Z. (2023). The potential of cystatin C as a predictive biomarker in pulmonary hypertension. BMC Pulmonary Medicine, 23(1). https://doi.org/10.1186/s12890-023-02595-1

9. Ferguson, T. W., Komenda, P., & Tangri, N. (2015). Cystatin C as a biomarker for estimating glomerular filtration rate. Current Opinion in Nephrology & Hypertension, 24(3), 295. https://doi.org/10.1097/mnh.0000000000000115

10. Gupta, K., Nayyar, S. B., Sachdeva, J. K., & Kumar, P. (2017). Cystatin C in the early diagnosis of diabetic nephropathy and its correlation with albuminuria. International Journal of Advances in Medicine, 4(1), 56. https://doi.org/10.18203/2349-3933.ijam20170020

11. Hassan, M. G., Aboelnaga, M. M., Al-Arman, M., & Hatata, E.-S. Z. (2021). Urinary cystatin C as a biomarker of early renal dysfunction in type 2 diabetic patients. Diabetes & Metabolic Syndrome Clinical Research & Reviews, 15(4), 102152. https://doi.org/10.1016/j.dsx.2021.05.025

12. Inker, L. A., Schmid, C. H., Tighiouart, H., Eckfeldt, J. H., Feldman, H. I., Greene, T., Kusek, J. W., Manzi, J., Lente, F. V., Zhang, Y. L., Coresh, J., & Levey, A. S. (2012). Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C. New England Journal of Medicine, 367(1), 20. https://doi.org/10.1056/nejmoa1114248

13. Ismael, A., Raoof, A., & Tahseen, Y. H. (2024). Assessing the accuracy of cystatin C for estimating glomerular filtration rate in patients with kidney disease. Asia-Pacific Journal of Molecular Biology and Biotechnology, 39. https://doi.org/10.35118/apjmbb.2024.032.4.05

14. Jasem, A. H., Haddad, N., Yaseen, N. T., & Alrufaie, M. M. (2024). Association of TGF-β1 with cystatin-C in patients with diabetic nephropathy. Anaesthesia Pain & Intensive Care, 28(1), 151. https://doi.org/10.35975/apic.v28i1.2399

15. Jeon, Y. K., Kim, M. R., Huh, J. E., Mok, J. Y., Song, S. H., Kim, S. S., Kim, B. H., Lee, S. H., Kim, Y. K., & Kim, I. J. (2011). Cystatin C as an Early Biomarker of Nephropathy in Patients with Type 2 Diabetes. Journal of Korean Medical Science, 26(2), 258. https://doi.org/10.3346/ jkms.2011.26.2.258

16. Karimi, F., Moazamfard, M., Taghvaeefar, R., Sohrabipour, S., Dehghani, A., Azizi, R., & Dinarvand, N. (2024). Early Detection of Diabetic Nephropathy Based on Urinary and Serum Biomarkers: An Updated Systematic Review. PubMed, 13, 104. https://doi.org/10.4103/abr. abr_461_23

17. Khader, N. A., Kamath, V., Kamath, S., Rao, I. R., & Prabhu, R. (2025). Kidney function estimation equations: a narrative review. Irish Journal of Medical Science (1971 -), 194(2), 725. https://doi.org/10.1007/s11845-025-03874-y

18. Khalid, U., Haroon, Z. H., Aamir, M., Ain, Q. U., Mansoor, K., Jaffar, S. R., & Khalid, U. (2020). Comparison of Estimated Glomerular Filtration Rate with Both Serum Creatinine and Cystatin C (eGFRcr-cys) versus Single Analyte (eGFRcr or eGFRcys) Using CKD-EPI and MDRD Equations in Tertiary Care Hospital Settings. Journal of College of Physicians And Surgeons Pakistan, 30(7), 701. https://doi.org/10.29271/jcpsp.2020.07.701

19. Khang, A. R., Lee, M. J., Yi, D., & Kang, Y. H. (2023). The Ratio of Estimated Glomerular Filtration Rate Based on Cystatin C and Creatinine Reflecting Cardiovascular Risk in Diabetic Patients. Diabetes & Metabolism Journal, 47(3), 415. https://doi.org/10.4093/dmj.2022.0177

20. Kim, M., Kim, S., Kim, S. H., Shin, J., Choi, S.-H., Chung, J.-W., & Hwang, J. H. (2020). Efficacy and Safety of Cystatin C-Guided Renal Dose Adjustment of Cefepime Treatment in Hospitalized Patients with Pneumonia. Journal of Clinical Medicine, 9(9), 2803. https://doi.org/ 10.3390/jcm9092803

21. Lees, J. S., & Mark, P. B. (2020). Cystatin C to predict renal disease and cardiovascular risk. Nephrology Dialysis Transplantation, 36(1), 39. https://doi.org/10.1093/ndt/gfaa152

22. Lees, J. S., Rutherford, E., Stevens, K., Chen, D. C., Scherzer, R., Estrella, M. M., Sullivan, M., Ebert, N., Mark, P. B., & Shlipak, M. G. (2022). Assessment of Cystatin C Level for Risk Stratification in Adults With Chronic Kidney Disease. JAMA Network Open, 5(10). https://doi.org/10. 1001/jamanetworkopen.2022.38300

23. Lees, J. S., Welsh, C., Celis‐Morales, C., Mackay, D., Lewsey, J., Gray, S. R., Lyall, D. M., Cleland, J. G. F., Gill, J. M. R., Jhund, P. S., Pell, J. P., Sattar, N., Welsh, P., & Mark, P. B. (2019). Glomerular filtration rate by differing measures, albuminuria and prediction of cardiovascular disease, mortality and end-stage kidney disease. Nature Medicine, 25(11), 1753. https://doi.org/ 10.1038/s41591-019-0627-8

24. Li, H.-H., Chai, H., Zhang, X., Yan, Z., & Gao, S. (2021). Value Analysis of the Combined Detection of Cystatin C, Hypersensitive C-reactive protein and Urinary Microalbumin in the Diagnosis of Early Renal Damage in Diabetes. Indian Journal of Pharmaceutical Sciences, 83. https://doi.org/10.36468/pharmaceutical-sciences.spl.193

25. Luke, B. S., & John, A. C. (2023). A comparative study of serum cystatin C levels in Type 2 diabetes mellitus with and without microalbuminuria. Asian Journal of Medical Sciences, 14(10), 83. https://doi.org/10.3126/ajms.v14i10.55350

26. Madero, M., & Sarnak, M. J. (2009). Association of cystatin C with adverse outcomes [Review of Association of cystatin C with adverse outcomes]. Current Opinion in Nephrology & Hypertension, 18(3), 258. Lippincott Williams & Wilkins. https://doi.org/10.1097/mnh.0b013e3283 26f3dd

27. Mahashabde, M., Chauhan, R., Paidi, S. K. R., & Sriram, P. J. (2025). Study of Cystatin C and Renal Resistive Index in Type 2 Diabetes Mellitus Patients to Detect Early Diabetic Kidney Disease. Annals of African Medicine, 25(2), 424. https://doi.org/10.4103/aam.aam_124_25

28. Mansour, A., Abdelmoniem, R. O., Elbadawy, A., & Ibrahim, W. M. (2023). The utility of estimation of glomerular filtration rate by serum cystatin C as a predictor of diabetic kidney disease in both type I and type II diabetic patients: a single center study. The Egyptian Journal of Internal Medicine, 35(1). https://doi.org/10.1186/s43162-023-00243-y

29. Medical Complications of Type 2 Diabetes. (2011). In InTech eBooks. https://doi.org/10. 5772/867

30. MM, T., Mahdy-Abdallah, H., EM, S., MA, H., & El-Leithy, LS. (2022). Diagnostic efficacy of serum cystatin-c in association with ACE I/D and ACE G2350A gene as predictor of renal insufficiency in T2DM patients. Research Square (Research Square). https://doi.org/10.21203/rs.3.rs-1745771/v1

31. Nguyen, H. H., Nguyen, L., Nguyen, T. Q., Le, P. H., Nguyễn, T., Nguyen, N. M., & Nguyen, K. T. (2022). Sensitivity and specificity of serum cystatin C and creatinine in detecting early stages of chronic kidney disease in Vietnamese patients with hypertension. Arterial Hypertension, 26(4), 153. https://doi.org/10.5603/ah.a2022.0021

32. Qiu, X., Liu, C., Ye, Y., Li, H., Chen, Y., Fu, Y., Liu, Z., Huang, X., Zhang, Y., Liao, X., Liu, H., Zhao, W., & Liu, X. (2017). The diagnostic value of serum creatinine and cystatin c in evaluating glomerular filtration rate in patients with chronic kidney disease: a systematic literature review and meta-analysis. Oncotarget, 8(42), 72985. https://doi.org/10.18632/oncotarget.20271

33. Rothenbacher, D., Rehm, M., Iacoviello, L., Costanzo, S., Tunstall‐Pedoe, H., Belch, J. J. F., Söderberg, S., Hultdin, J., Salomaa, V., Jousilahti, P., Linneberg, A., Sans, S., Padró, T., Thorand, B., Meisinger, C., Kee, F., McKnight, A. J., Palosaari, T., Kuulasmaa, K., … Köenig, W. (2020). Contribution of cystatin C- and creatinine-based definitions of chronic kidney disease to cardiovascular risk assessment in 20 population-based and 3 disease cohorts: the BiomarCaRE project. BMC Medicine, 18(1). https://doi.org/10.1186/s12916-020-01776-7

34. Sagar, P. V., Shekhar, R., Kumari, B., Singh, P. P., & Kumar, P. (2025). Evaluating the Diagnostic Utility of Cystatin C versus Creatinine in Chronic Kidney Disease: A Cross-Sectional Analysis. Cureus, 17(12). https://doi.org/10.7759/cureus.98573

35. Sajid, I., Saeed, R., Goheer, A., Asghar, S., Saqib, S., & Bashir, F. (2024). Diagnostic Accuracy of Serum Cystatin C for Early Detection of Kidney Damage in Patients with Type II Diabetes Mellitus: Bahawalpur, Pakistan. Life and Science, 5(1), 7. https://doi.org/10.37185/lns. 1.1.559

36. Salman, M. N., kzar, A. J., & Hamzah, A. S. (2022). Determination of Cystatin C Level in a Sample of Patients with Chronic Kidney Disease. Journal of Techniques, 4(33), 7. https://doi.org/ 10.51173/jt.v4i33.520

37. Sapkota, S., Khatiwada, S., Shrestha, S., Baral, N., Maskey, R., Majhi, S., Chandra, L., & Lamsal, M. (2021). Diagnostic Accuracy of Serum Cystatin C for Early Recognition of Nephropathy in Type 2 Diabetes Mellitus. International Journal of Nephrology, 2021, 1. https://doi.org/ 10.1155/2021/8884126

38. Shlipak, M. G., Matsushita, K., Ärnlöv, J., Inker, L. A., Katz, R., Polkinghorne, K. R., Rothenbacher, D., Sarnak, M. J., Astor, B. C., Coresh, J., Levey, A. S., & Gansevoort, R. T. (2013). Cystatin C versus Creatinine in Determining Risk Based on Kidney Function. New England Journal of Medicine, 369(10), 932. https://doi.org/10.1056/nejmoa1214234

39. Sonkar, S. K., Bhosale, V., & Durgapal, K. (2024). Evaluation of Cystatin C and Performance of Cystatin C Based Equations for Calculating GFR in Management of Chronic Kidney Disease Patients. International Journal of Health Sciences and Research, 14(10), 390. https://doi.org/10.52403/ijhsr.20241042

40. Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B. J., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., Lamb, E. J., Lin, P., Madero, M., McIntyre, N. J., Morrow, K., Roberts, G. V., Sabanayagam, D., Schäeffner, E., Shlipak, M. G., … Levin, A. (2024). KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International, 105(4). https://doi.org/10.1016/j.kint.2023.10.018

41. Taha, M. M., Mahdy-Abdallah, H., Shahy, E. M., Helmy, M., & Ellaithy, L. S. (2023). Diagnostic efficacy of cystatin-c in association with different ACE genes predicting renal insufficiency in T2DM. Scientific Reports, 13(1). https://doi.org/10.1038/s41598-023-32012-w

42. Tio, M. C., Shafi, T., Zhu, X., Kalantar‐Zadeh, K., Chan, A., & Nguyen, L. (2022). Traditions and innovations in assessment of glomerular filtration rate using creatinine to cystatin C. Current Opinion in Nephrology & Hypertension, 32(1), 89. https://doi.org/10.1097/mnh.0000000000 000854

43. Waheed, S., Matsushita, K., Astor, B. C., Hoogeveen, R. C., Ballantyne, C. M., & Coresh, J. (2012). Combined Association of Creatinine, Albuminuria, and Cystatin C with All-Cause Mortality and Cardiovascular and Kidney Outcomes. Clinical Journal of the American Society of Nephrology, 8(3), 434. https://doi.org/10.2215/cjn.04960512